NRIX Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

03

Fiyat $22.99

Piyasa Değeri (MRQ) $2.38B

P/E (TTM) -6.6

Hisse Başına Kâr (TTM) $-3.46

Gelir (TTM) $37M

ROE (TTM) -80.3%

52 Haftlık Aralık $9–$28

NRIX Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

04

aralık

çubuklar

Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.

Nurix Therapeutics, Inc. - Common stock Hakkında Wikipedia'dan şirket genel bakışı

05 · wikidata

Wikidata ↗

sektörHealthcare endüstriBiotechnology çalışanlar317 ülkeUS

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

06

Gelir$84M

2019-11-30 → 2025-11-30

Hisse Başına Kâr$-3.05

2021-11-30 → 2025-11-30

Serbest Nakit Akışı$-263M

2020-11-30 → 2025-11-30

Net kar marjı-928.4%

2020-11-30 → 2025-11-30

Değerleme ve Oranlar 07–12

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik	NRIX	5Y ort.	Akran Ortalaması	Sonuç
P/E (TTM)	-6.65Y ort. ≈-5.9	≈-5.9	·	·
F/S (TTM)	64.85Y ort. ≈22.9	≈22.9	50.1	Adil değer
F/D (MRQ)	5.95Y ort. ≈2.7	≈2.7	4.5	Adil değer
Price / FCF (Fiyat / Serbest Nakit Akışı)	-8.95Y ort. ≈-7.4	≈-7.4	·	·
Price / Cash Flow (Fiyat / Nakit Akışı)	-9.45Y ort. ≈-7.9	≈-7.9	·	·
Price / Tangible Book (Fiyat / Maddi Defter Değeri)	4.35Y ort. ≈2.7	≈2.7	·	·

Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik	NRIX	5Y ort.	Akran Ortalaması	Sonuç
Faaliyet Kâr Marjı (TTM)	-982.4%5Y ort. ≈-360.9%	≈-360.9%	-7718.9%	En üst düzey
EBITDA Margin (FAVÖK Marjı)	-340.2%5Y ort. ≈-360.9%	≈-360.9%	-7701.1%	En üst düzey
Pretax Margin (Vergi Öncesi Kar Marjı)	-314.0%5Y ort. ≈-343.2%	≈-343.2%	-525.2%	Zayıf
Net Kâr Marjı (TTM)	-928.4%5Y ort. ≈-343.5%	≈-343.5%	-7584.4%	En üst düzey
ROA (TTM)	-60.6%5Y ort. ≈-36.2%	≈-36.2%	-37.6%	Zayıf
ROE (TTM)	-80.3%5Y ort. ≈-50.2%	≈-50.2%	-43.8%	Zayıf
ROIC	-53.2%5Y ort. ≈-47.2%	≈-47.2%	-39.9%	Zayıf

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik	5 Yıllık trend	NRIX	5Y ort.	Akran Ortalaması	Sonuç
Cari Oran (MRQ)		6.35Y ort. ≈5.2	≈5.2	14.6	Düşük likidite
Quick Ratio (Cari Oran)		2.95Y ort. ≈2.7	≈2.7	10.3	Düşük likidite

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Metrik	NRIX	5Y ort.	Akran Ortalaması	Sonuç
Revenue YoY (Gelir Yıllık Bazda)	53.9%5Y ort. ≈44.2%	≈44.2%	·	·
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)	29.5%5Y ort. ≈38.3%	≈38.3%	·	·
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)	36.4%	·	·	·

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik	NRIX	5Y ort.	Akran Ortalaması	Sonuç
EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))	$-3.055Y ort. ≈$-3.00	≈$-3.00	·	·
Revenue / Share (Hisse Başına Gelir)	$0.975Y ort. ≈$1.00	≈$1.00	·	·
Cash Flow / Share (Hisse Başına Nakit Akışı)	$-2.885Y ort. ≈$-2.56	≈$-2.56	·	·
Cash / Share (Hisse Başına Nakit)	$2.435Y ort. ≈$1.63	≈$1.63	·	·

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik	5 Yıllık trend	NRIX	5Y ort.	Akran Ortalaması	Sonuç
Asset Turnover (Aktif Devir Hızı)		0.15Y ort. ≈0.1	≈0.1	0.1	En üst düzey
Revenue / Employee (Çalışan Başına Gelir)		≈$264.9K	·	·	·

değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

14

Ort. Sürpriz 3.0%

Sonraki Rapor Eki 07, 2026

Dönem	Rapor	EPS Gerçek	EPS Tahmin	Sürpriz
30 Haziran 2026	Tem 7, 2026	$-0.81	$-0.73	-10.8%
31 Mart 2026		$-0.79	$-0.77	-2.7%
31 Aralık 2025		$-0.82	$-0.89	7.7%
30 Eylül 2025		$-1.03	$-0.86	-20.0%
30 Haziran 2025		$-0.52	$-0.74	30.1%
31 Mart 2025		$-0.67	$-0.78	14.0%

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

15

Gelir Tablosu 13

Metrik	2025	2024	2023	2022	2021	2020	2019
Revenue	$84M	$55M	$77M	$39M	$30M	$18M	$31M
R&D Expense	$317M	$222M	$189M	$184M	$116M	$66M	$45M
SG&A Expense	$53M	$46M	$43M	$38M	$31M	$16M	$8M
Operating Expenses	$370M	$268M	$232M	$222M	$148M	$83M	$53M
Operating Income	$-286M	$-213M	$-155M	$-184M	$-118M	$-65M	$-22M
Pretax Income	$-264M	$-193M	$-144M	$-180M	$-117M	$-64M	$-21M
Income Tax	$760.0K	$270.0K	$0	$0	$131.0K	$-21M	$239.0K
Net Income	$-264M	$-194M	$-144M	$-180M	$-117M	$-43M	$-22M
EPS (Basic)	$-3.05	$-2.88	$-2.65	$-3.71	$-2.73	·	·
EPS (Diluted)	$-3.05	$-2.88	$-2.65	$-3.71	$-2.73	·	·
Shares (Basic)	86,666,907	67,120,266	54,337,901	48,607,990	42,895,383	·	·
Shares (Diluted)	86,666,907	67,120,266	54,337,901	48,607,990	42,895,383	·	·
EBITDA	$-286M	$-213M	$-155M	$-184M	$-118M	$-65M	·

Bilanço 21

Metrik	2025	2024	2023	2022	2021	2020	2019
Cash & Equivalents	$247M	$110M	$55M	$64M	$81M	$119M	$35M
Short-term Investments	·	·	·	$245M	$215M	$162M	$3M
Receivables	·	$0	·	$0	$6M	·	·
Prepaid Expense	$14M	$10M	$8M	$9M	$9M	$6M	$2M
Current Assets	$607M	$619M	$296M	$318M	$311M	$298M	$39M
PP&E (Net)	$22M	$18M	$17M	$17M	$11M	$7M	$4M
PP&E (Gross)	$60M	$52M	$43M	$37M	$26M	$20M	$15M
Accum. Depreciation	$38M	$35M	$26M	$20M	$15M	$13M	$11M
Other Non-current Assets	$7M	$3M	$4M	$4M	$3M	$177.0K	$147.0K
Total Assets	$688M	$669M	$356M	$417M	$477M	$396M	$44M
Accounts Payable	$11M	$11M	$6M	$5M	$7M	$3M	$2M
Current Liabilities	$86M	$96M	$87M	$71M	$66M	$45M	$16M
Capital Leases	$53M	$20M	$23M	$6M	$9M	·	·
Other Non-current Liabilities	·	·	·	·	·	$850.0K	$2M
Total Liabilities	$149M	$142M	$155M	$113M	$134M	$106M	$54M
Common Stock	$102.0K	$76.0K	$49.0K	$47.0K	$45.0K	$39.0K	$4.0K
Retained Earnings	$-1.00B	$-739M	$-545M	$-401M	$-221M	$-104M	$-60M
AOCI	$105.0K	$150.0K	$-655.0K	$-4M	$-608.0K	$87.0K	$-2.0K
Stockholders' Equity	$539M	$527M	$200M	$304M	$342M	$290M	$-58M
Liabilities + Equity	$688M	$669M	$356M	$417M	$477M	$396M	$44M
Shares Outstanding	101,807,484	75,870,718	48,718,552	47,172,299	44,664,371	38,864,872	3,595,334

Nakit Akışı 11

Metrik	2025	2024	2023	2022	2021	2020	2019
D&A	$9M	$9M	$8M	$5M	$3M	$2M	$2M
Stock-based Comp	$38M	$34M	$34M	$28M	$16M	$4M	$510.0K
Operating Cash Flow	$-249M	$-173M	$-81M	$-160M	$-84M	$-80.0K	$601.0K
CapEx	$14M	$9M	$8M	$12M	$6M	$5M	$2M
Investing Cash Flow	$148M	$-258M	$68M	$27M	$-108M	$-254M	$8M
Stock Issued	$0	$290M	$0	$19M	$150M	$218M	·
Net Stock Activity	$0	$290M	$0	$19M	$150M	$218M	·
Financing Cash Flow	$239M	$486M	$3M	$117M	$154M	$339M	$126.0K
Net Change in Cash	$137M	$55M	$-10M	$-15M	$-39M	$85M	$9M
Taxes Paid	·	·	·	·	·	$1.0K	$1.0K
Free Cash Flow	$-263M	$-182M	$-90M	$-172M	$-90M	$-5M	·

Kârlılık 7

Metrik	2025	2024	2023	2022	2021	2020	2019
Operating Margin	-340.2%	-390.5%	-201.4%	-476.0%	-396.3%	-364.7%	·
Net Margin	-314.9%	-354.9%	-187.0%	-466.9%	-393.9%	-242.7%	·
Pretax Margin	-314.0%	-354.4%	-187.0%	-466.9%	-393.5%	-357.9%	·
EBITDA Margin	-340.2%	-390.5%	-201.4%	-476.0%	-396.3%	-364.7%	·
ROA	-39.0%	-37.8%	-37.3%	-40.4%	-26.9%	-19.6%	·
ROE	-53.6%	-42.8%	-66.3%	-55.8%	-32.7%	-14.5%	·
ROIC	-53.2%	-40.5%	·	-60.5%	-34.5%	-15.2%	·

Likidite ve Solventlik 2

Metrik	Eğilim	2025	2024	2023	2022	2021	2020	2019
Current Ratio		7.0	6.5	3.4	4.5	4.7	6.7	·
Quick Ratio		2.9	1.1	0.6	4.4	4.6	6.3	·

Verimlilik 2

Metrik	Eğilim	2025	2024	2023	2022	2021	2020	2019
Asset Turnover		0.1	0.1	0.2	0.1	0.1	0.1	·
Receivables Turnover		·	·	·	12.9	9.9	·	·

Hisse Başına 6

Metrik	2025	2024	2023	2022	2021	2020	2019
Book Value / Share	$5.29	$6.95	$4.12	$6.44	$7.66	$7.47	·
Revenue / Share	$0.97	$0.81	$1.42	$0.79	·	·	·
Cash Flow / Share	$-2.88	$-2.57	$-1.50	$-3.29	·	·	·
Cash / Share	$2.43	$1.45	$1.12	$1.37	$1.80	$3.07	·
Dividend / Share	$0.00	$0.00	·	·	·	$0.00	$0.00
EPS (TTM)	$-3.05	$-2.88	$-2.65	$-3.71	$-2.73	·	·

Büyüme Oranları 3

Metrik	2025	2024	2023	2022	2021	2020	2019
Revenue YoY	53.9%	-29.1%	99.3%	29.8%	67.0%	·	·
Revenue CAGR 3Y	29.5%	22.4%	62.9%	·	·	·	·
Revenue CAGR 5Y	36.4%	·	·	·	·	·	·

Değerleme (TTM) 10

Metrik	2025	2024	2023	2022	2021	2020	2019
Revenue TTM	$84M	$55M	$77M	$39M	$30M	$18M	·
Net Income TTM	$-264M	$-194M	$-144M	$-180M	$-117M	$-43M	·
Market Cap	$1.80B	$1.68B	$303M	$584M	$1.29B	$1.66B	·
P/E	-5.8	-7.7	-2.3	-3.3	-10.6	·	·
P/S	21.4	30.8	3.9	15.1	43.3	93.0	·
P/B	3.3	3.2	1.5	1.9	3.8	5.7	·
P / Tangible Book	3.3	3.2	1.5	1.9	3.8	5.7	·
P / Cash Flow	-7.2	-9.7	-3.7	-3.7	-15.3	-20705.3	·
P / FCF	-6.8	-9.2	-3.4	-3.4	-14.3	-357.5	·
Earnings Yield	-17.2%	-13.0%	-42.6%	-29.9%	-9.5%	·	·

Gelir Tablosu 13

Metrik	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$9M	$6M	$14M	$8M	$44M	$18M	$13M	$13M	$12M	$17M	$15M	$18M	$31M	$13M	$7M	$11M
R&D Expense	$88M	$84M	$83M	$86M	$78M	$70M	$67M	$55M	$49M	$50M	$50M	$48M	$46M	$46M	$46M	$48M
SG&A Expense	$16M	$15M	$14M	$13M	$14M	$12M	$11M	$12M	$12M	$12M	$11M	$11M	$12M	$10M	$9M	$10M
Operating Expenses	$103M	$99M	$97M	$99M	$92M	$81M	$78M	$67M	$61M	$62M	$60M	$58M	$57M	$56M	$55M	$58M
Operating Income	$-94M	$-92M	$-83M	$-91M	$-48M	$-63M	$-65M	$-55M	$-49M	$-45M	$-45M	$-40M	$-27M	$-43M	$-49M	$-47M
Pretax Income	$-90M	·	$-78M	$-86M	$-43M	$-56M	$-59M	$-49M	$-44M	$-41M	$-42M	$-37M	$-24M	$-41M	$-47M	$-46M
Income Tax	$-271.0K	$0	$0	$0	$760.0K	$0	$8.0K	$82.0K	$90.0K	$90.0K	$0	$0	$0	$0	$0	$0
Net Income	$-90M	$-87M	$-78M	$-86M	$-43M	$-56M	$-59M	$-49M	$-45M	$-42M	$-42M	$-37M	$-24M	$-41M	$-47M	$-46M
EPS (Basic)	$-0.81	$-0.79	$-0.83	$-1.03	$-0.52	$-0.67	$-0.74	$-0.67	$-0.71	$-0.76	$-0.77	$-0.68	$-0.45	$-0.75	$-0.85	$-0.90
EPS (Diluted)	$-0.81	$-0.79	$-0.83	$-1.03	$-0.52	$-0.67	$-0.74	$-0.67	$-0.71	$-0.76	$-0.77	$-0.68	$-0.45	$-0.75	$-0.85	$-0.90
Shares (Basic)	111,084,423	110,071,668	·	84,159,336	83,882,477	83,560,795	·	72,779,381	62,377,551	54,903,407	·	54,390,859	54,259,045	54,028,238	·	50,868,542
Shares (Diluted)	111,084,423	110,071,668	·	84,159,336	83,882,477	83,560,795	·	72,779,381	62,377,551	54,903,407	·	54,390,859	54,259,045	54,028,238	·	50,868,542
EBITDA	$-94M	$-92M	·	$-91M	$-48M	$-63M	·	$-55M	$-49M	$-45M	·	$-40M	$-27M	$-43M	·	$-47M

Bilanço 20

Metrik	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$68M	$71M	$247M	$78M	$84M	$76M	$110M	$99M	$117M	$50M	$55M	$42M	$59M	$34M	$64M	$48M
Short-term Investments	·	·	·	·	·	·	·	·	·	·	·	$217M	$222M	$244M	·	$297M
Receivables	·	·	·	·	$19M	·	·	·	·	·	·	$2M	·	·	·	·
Prepaid Expense	$13M	$14M	$14M	$12M	$11M	$14M	$10M	$8M	$7M	$7M	·	$7M	$9M	$11M	·	$10M
Current Assets	$456M	$554M	$607M	$441M	$515M	$564M	$619M	$456M	$450M	$251M	·	$268M	$290M	$288M	·	$355M
PP&E (Net)	$20M	$22M	$22M	$20M	$19M	$18M	$18M	$17M	$19M	$18M	·	$17M	$18M	$18M	·	$17M
PP&E (Gross)	$61M	$61M	$60M	$61M	$57M	$55M	$52M	$49M	$48M	$46M	·	$42M	$42M	$39M	·	$35M
Accum. Depreciation	$41M	$40M	$38M	$41M	$39M	$37M	$35M	$32M	$30M	$28M	·	$25M	$23M	$21M	·	$18M
Other Non-current Assets	$8M	$7M	$7M	$7M	$6M	$6M	$3M	$3M	$3M	$3M	·	$4M	$4M	$4M	·	$4M
Total Assets	$536M	$636M	$688M	$522M	$592M	$615M	$669M	$514M	$511M	$313M	·	$308M	$351M	$370M	·	$459M
Accounts Payable	$12M	$10M	$11M	$9M	$6M	$8M	$11M	$4M	$3M	$6M	·	$2M	$5M	$6M	·	$6M
Current Liabilities	$72M	$92M	$86M	$82M	$76M	$90M	$96M	$86M	$81M	$88M	·	$61M	$72M	$65M	·	$68M
Capital Leases	$55M	$55M	$53M	$53M	$47M	$20M	$20M	$21M	$21M	$22M	·	$3M	$4M	$5M	·	$8M
Total Liabilities	$133M	$155M	$149M	$150M	$144M	$134M	$142M	$137M	$140M	$144M	·	$74M	$91M	$96M	·	$117M
Common Stock	$104.0K	$103.0K	$102.0K	$77.0K	$76.0K	$76.0K	$76.0K	$67.0K	$64.0K	$49.0K	·	$49.0K	$48.0K	$47.0K	·	$47.0K
Retained Earnings	$-1.18B	$-1.09B	$-1.00B	$-925M	$-839M	$-795M	$-739M	$-680M	$-631M	$-587M	·	$-503M	$-466M	$-442M	·	$-355M
AOCI	$-145.0K	$56.0K	$105.0K	$119.0K	$-20.0K	$226.0K	$150.0K	$344.0K	$-135.0K	$-350.0K	·	$-1M	$-2M	$-3M	·	$-4M
Stockholders' Equity	$403M	$481M	$539M	$372M	$448M	$481M	$527M	$377M	$371M	$169M	$200M	$234M	$260M	$274M	$304M	$343M
Liabilities + Equity	$536M	$636M	$688M	$522M	$592M	$615M	$669M	$514M	$511M	$313M	·	$308M	$351M	$370M	·	$459M
Shares Outstanding	103,701,511	103,399,813	101,807,484	76,872,686	76,433,664	76,234,799	75,870,718	67,083,523	64,356,535	49,136,954	·	48,503,768	47,631,208	47,444,853	·	47,147,781

Nakit Akışı 10

Metrik	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	·	$2M	$2M	$2M	$2M	$2M	$3M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M
Stock-based Comp	·	$9M	$9M	$10M	$10M	$9M	$9M	$9M	$9M	$8M	$8M	$8M	$9M	$8M	$8M	$7M
Operating Cash Flow	·	$-72M	$-68M	$-57M	$-63M	$-61M	$-49M	$-42M	$-40M	$-42M	$27M	$-41M	$-18M	$-48M	$-38M	$-46M
CapEx	·	$1M	$5M	$3M	$3M	$3M	$2M	$2M	$2M	$3M	$3M	$2M	$1M	$2M	$3M	$3M
Investing Cash Flow	·	$-124M	$346.0K	$50M	$71M	$26M	$-141M	$-21M	$-131M	$36M	$-14M	$23M	$44M	$16M	$55M	$-63M
Stock Issued	·	$18M	$0	$0	·	$0	$199M	$42M	·	·	$0	$0	·	·	$0	·
Net Stock Activity	·	$18M	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Financing Cash Flow	·	$20M	$236M	$1M	$6.0K	$1M	$201M	$46M	$238M	$2M	$7.0K	$2M	$25.0K	$1M	$-135.0K	$115M
Net Change in Cash	·	$-176M	$169M	$-6M	$8M	$-34M	$11M	$-18M	$67M	$-5M	$12M	$-17M	$25M	$-31M	$17M	$6M
Free Cash Flow	·	$-73M	·	·	·	$-65M	·	·	·	$-45M	·	·	·	$-51M	·	·

Kârlılık 7

Metrik	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-1041.7%	-1479.4%	·	-1157.6%	-109.7%	-340.7%	·	-433.8%	-401.4%	-272.7%	·	-216.7%	-87.2%	-338.6%	·	-432.9%
Net Margin	-990.1%	-1394.3%	·	-1094.8%	-98.7%	-305.4%	·	-388.9%	-368.4%	-250.3%	·	-200.3%	-79.1%	-321.1%	·	-423.6%
Pretax Margin	-993.1%	·	·	-1094.8%	-96.9%	-305.4%	·	-388.3%	-367.6%	-249.8%	·	·	·	·	·	-423.6%
EBITDA Margin	-1041.7%	-1479.4%	·	-1157.6%	-109.7%	-340.7%	·	-433.8%	-401.4%	-272.7%	·	-216.7%	-87.2%	-338.6%	·	-432.9%
ROA	-15.9%	·	·	-16.7%	-7.9%	-12.2%	·	-11.9%	-10.3%	-12.2%	·	-9.6%	-6.5%	-10.1%	·	-9.6%
ROE	-21.1%	·	·	-23.1%	-10.6%	-17.3%	·	-16.0%	-14.1%	-18.8%	·	-12.8%	-9.2%	-14.1%	·	-12.7%
ROIC	-23.3%	·	·	-24.6%	-11.0%	-13.1%	·	-14.5%	-13.1%	-26.9%	·	·	·	·	·	-13.6%

Likidite ve Solventlik 2

Metrik	Eğilim	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio		6.3	·	·	5.4	6.8	6.3	·	5.3	5.6	2.9	·	4.4	4.0	4.4	·	5.3
Quick Ratio		0.9	·	·	1.0	1.4	0.8	·	1.1	1.4	0.6	·	4.2	3.9	4.3	·	5.1

Verimlilik 2

Metrik	Eğilim	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.0	·	·	0.0	0.1	0.0	·	0.0	0.0	0.0	·	0.0	0.1	0.0	·	0.0
Receivables Turnover		·	·	·	·	4.1	·	·	·	·	·	·	18.5	·	·	·	·

Hisse Başına 6

Metrik	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$3.88	·	·	$4.84	$5.86	$6.31	·	$5.62	$5.76	$3.43	·	$4.82	$5.46	$5.78	·	$7.27
Revenue / Share	$0.08	$0.06	·	$0.09	$0.53	$0.22	·	$0.17	$0.19	$0.30	·	$0.34	$0.57	$0.23	·	$0.21
Cash Flow / Share	·	$-0.65	·	·	·	$-0.73	·	·	·	$-0.76	·	·	·	$-0.90	·	·
Cash / Share	$0.65	·	·	$1.02	$1.10	$1.00	·	$1.48	$1.81	$1.01	·	$0.87	$1.24	$0.71	·	$1.01
Dividend / Share	·	$0.00	$0.00	$0.00	$0.00	$0.00	·	$0.00	$0.00	$0.00	·	$0.00	$0.00	$0.00	·	$0.00
EPS (TTM)	$-3.46	$-3.17	·	·	·	·	·	$-2.91	$-2.92	$-2.66	·	$-2.73	$-2.95	$-3.51	·	$-3.71

Değerleme (TTM) 9

Metrik	Q2 2026	Q4 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$37M	$77M	·	·	·	·	·	$56M	$62M	$81M	·	$69M	$61M	$42M	·	$39M
Net Income TTM	·	$-273M	·	·	·	·	·	$-177M	$-165M	$-145M	·	$-149M	$-157M	$-179M	·	$-171M
Market Cap	$1.84B	·	·	$718M	$812M	$1.18B	·	$1.69B	$1.01B	$607M	·	$412M	$482M	$447M	·	$742M
P/E	-5.1	-5.3	·	·	·	·	·	-8.7	-5.4	-4.6	·	-3.1	-3.4	-2.7	·	-4.2
P/S	50.1	·	·	·	·	·	·	30.0	16.3	7.5	·	6.0	7.9	10.7	·	18.9
P/B	4.6	·	·	1.9	1.8	2.4	·	4.5	2.7	3.6	·	1.8	1.9	1.6	·	2.2
P / Tangible Book	4.6	·	·	1.9	1.8	2.4	·	4.5	2.7	3.6	·	1.8	1.9	1.6	·	2.2
P / Cash Flow	·	·	·	·	·	-19.3	·	·	·	-14.5	·	·	·	-9.2	·	·
Earnings Yield	-19.5%	-18.9%	·	·	·	·	·	-11.6%	-18.5%	-21.5%	·	-32.1%	-29.1%	-37.2%	·	-23.6%

En son dönem solda · null değerler · olarak gösterilir

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

16

Metrik	2025-11-30	2024-11-30	2023-11-30	2022-11-30	2021-11-30
Gelir	$84M	$55M	$77M	$39M	$30M
Faaliyet Kâr Marjı %	-340.2%	-390.5%	-201.4%	-476.0%	-396.3%
Net Gelir	$-264M	$-194M	$-144M	$-180M	$-117M
Seyreltilmiş Hisse Başı Kâr	$-3.05	$-2.88	$-2.65	$-3.71	$-2.73

Metrik	2025-11-30	2024-11-30	2023-11-30	2022-11-30	2021-11-30
Cari Oran	7.0	6.5	3.4	4.5	4.7
Cari Oran	2.9	1.1	0.6	4.4	4.6

Metrik	2025-11-30	2024-11-30	2023-11-30	2022-11-30	2021-11-30
Serbest Nakit Akışı	$-263M	$-182M	$-90M	$-172M	$-90M

Kurumsal Sahipler (13F) 223 dosya · $2.8B toplam · Tarih itibarıyla 30 Eylül 2026

17

Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.

Sahipler 223

Tutulan Değer $2.8B

Yeni pozisyonlar 47

Çıkan pozisyonlar 26

Kurumsal faaliyet — Q2 2026 ve önceki çeyrek

Yeni pozisyonlar	Çıkan pozisyonlar	Artırıldı	Azaldı	Net hisse senedi değişimi
47 (+3 önceki Ç'ye göre)	26 (0 önceki Ç'ye göre)	67 (-2 önceki Ç'ye göre)	63 (+20 önceki Ç'ye göre)	-283K

Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.

Kurum	Değer	Hisse senetleri	% izlenen 13F'nin	Tür
BlackRock, Inc.	$212.768.666	8.770.349	7,57%	Hisse senetleri
Vestal Point Capital, LP	$195.293.000	8.050.000	6,95%	Hisse senetleri
Deep Track Capital, LP	$187.686.398	7.736.455	6,68%	Hisse senetleri
Rubric Capital Management LP	$175.345.894	7.227.778	6,24%	Hisse senetleri
FMR LLC	$133.071.325	5.485.215	4,73%	Hisse senetleri
MORGAN STANLEY	$115.537.879	4.762.484	4,11%	Hisse senetleri
STATE STREET CORP	$113.469.939	4.677.244	4,04%	Hisse senetleri
BAKER BROS. ADVISORS LP	$113.016.569	4.658.556	4,02%	Hisse senetleri
VANGUARD GROUP INC	$112.862.243	5.949.512	4,01%	Hisse senetleri
VANGUARD CAPITAL MANAGEMENT LLC	$109.061.534	4.495.529	3,88%	Hisse senetleri
PERCEPTIVE ADVISORS LLC	$104.813.438	4.320.422	3,73%	Hisse senetleri
Redmile Group, LLC	$98.830.073	4.073.787	3,51%	Hisse senetleri
GENERAL ATLANTIC, L.P.	$73.560.808	3.032.185	2,62%	Hisse senetleri
GEODE CAPITAL MANAGEMENT, LLC	$61.566.526	2.537.291	2,19%	Hisse senetleri
Pictet Asset Management Holding SA	$57.040.888	2.351.232	2,03%	Hisse senetleri
ARK Investment Management LLC	$43.502.930	1.793.196	1,55%	Hisse senetleri
Capital World Investors	$43.374.842	1.787.916	1,54%	Hisse senetleri
Trails Edge Capital Partners, LP	$38.166.318	1.573.220	1,36%	Hisse senetleri
VANGUARD PORTFOLIO MANAGEMENT LLC	$35.974.208	1.482.861	1,28%	Hisse senetleri
CITADEL ADVISORS LLC	$35.832.481	1.477.019	1,27%	Hisse senetleri
Soleus Capital Management, L.P.	$35.544.854	1.465.163	1,26%	Hisse senetleri
DIMENSIONAL FUND ADVISORS LP	$34.720.069	1.431.317	1,23%	Hisse senetleri
EVENTIDE ASSET MANAGEMENT, LLC	$31.486.884	1.297.893	1,12%	Hisse senetleri
BRAIDWELL LP	$31.217.016	1.286.769	1,11%	Hisse senetleri
Kynam Capital Management, LP	$28.984.805	1.194.757	1,03%	Hisse senetleri
Woodline Partners LP	$25.812.786	1.064.006	0,92%	Hisse senetleri
Sumitomo Mitsui Trust Group, Inc.	$23.858.788	983.462	0,85%	Hisse senetleri
Amova Asset Management Americas, Inc.	$23.848.954	983.462	0,85%	Hisse senetleri
Affinity Asset Advisors, LLC	$23.474.461	967.620	0,83%	Hisse senetleri
UBS Group AG	$22.249.259	917.117	0,79%	Hisse senetleri
NORTHERN TRUST CORP	$21.253.458	876.070	0,76%	Hisse senetleri
BANK OF AMERICA CORP /DE/	$20.429.079	842.089	0,73%	Hisse senetleri
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$20.215.761	833.296	0,72%	Hisse senetleri
Nuveen, LLC	$20.034.709	825.833	0,71%	Hisse senetleri
GOLDMAN SACHS GROUP INC	$19.737.670	813.589	0,70%	Hisse senetleri
KENNEDY CAPITAL MANAGEMENT LLC	$17.576.564	724.508	0,63%	Hisse senetleri
VANGUARD FIDUCIARY TRUST CO	$16.650.560	686.338	0,59%	Hisse senetleri
Rhenman & Partners Asset Management AB	$16.599.905	684.250	0,59%	Hisse senetleri
RAYMOND JAMES FINANCIAL INC	$14.392.512	593.262	0,51%	Hisse senetleri
Sofinnova Investments, Inc.	$12.714.617	524.098	0,45%	Hisse senetleri
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	$11.575.441	477.141	0,41%	Hisse senetleri
Elmind Capital, LP	$11.159.600	460.000	0,40%	Hisse senetleri
CITIGROUP INC	$9.446.456	389.384	0,34%	Hisse senetleri
Candriam S.C.A.	$9.159.082	377.902	0,33%	Hisse senetleri
Fisher Asset Management, LLC	$8.963.219	369.465	0,32%	Hisse senetleri
JACOBS LEVY EQUITY MANAGEMENT, INC	$8.821.009	363.603	0,31%	Hisse senetleri
FIRST TRUST ADVISORS LP	$8.754.172	360.848	0,31%	Hisse senetleri
BNP PARIBAS FINANCIAL MARKETS	$8.262.422	340.578	0,29%	Hisse senetleri
WELLINGTON MANAGEMENT GROUP LLP	$8.106.188	334.138	0,29%	Hisse senetleri
ArrowMark Colorado Holdings LLC	$7.636.126	314.762	0,27%	Hisse senetleri

Tüm 223 kurumsal sahibi göster →

Şirket yöneticileri 20 içeriden öğrenenler · 6 yöneticiler · 11 yönetim kurulu üyeleri

19

İçeriden Öğrenen	Rol	Son işlem	Sahip olunan hisse senetleri	Satışlar 12ay	Net 12ay
Arthur T Sands	President, CEO	10 Şubat 2026 A	·	0	$0
Hans Van Houte	Chief Financial Officer	04 Ağustos 2026 S	40.166	10	$-635.401
Stefani Wolff	EVP and COO	30 Nisan 2023 M	6.113	0	$0
Christine Ring	Chief Legal Officer	02 Ekim 2026 M	9.110	21	$-3.398.693
Gwenn Hansen	Chief Scientific Officer	01 Eylül 2026 M	117.227	10	$-630.908
Pierre Beaurang	Chief Business Officer	10 Ağustos 2021 M	4.330	0	$0
Edward C Saltzman	Yönetim kurulu üyesi	15 Mayıs 2026 A	·	0	$0
Roger D Dansey	Yönetim kurulu üyesi	15 Mayıs 2026 A	·	0	$0
David L. Lacey	Yönetim kurulu üyesi	15 Mayıs 2026 A	·	0	$0
Anil Kapur	Yönetim kurulu üyesi	15 Mayıs 2026 A	·	0	$0
Roy D. Baynes	Yönetim kurulu üyesi	15 Mayıs 2026 A	·	0	$0
Paul M Silva	Yönetim kurulu üyesi	15 Mayıs 2026 A	·	0	$0
Lori Anne Kunkel	Yönetim kurulu üyesi	19 Mayıs 2025 A	0	0	$0
Clay B Siegall	Yönetim kurulu üyesi	05 Mayıs 2022 A	·	0	$0
Jeffrey K Tong	Yönetim kurulu üyesi	06 Mayıs 2021 A	·	0	$0
Robert Tjian	Yönetim kurulu üyesi	28 Temmuz 2020 C	124.999	0	$0
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.	10% sahip	28 Temmuz 2020 C	784.313	0	$0
Judith A Reinsdorf	·	15 Mayıs 2026 A	·	0	$0
Julia P Gregory	·	15 Mayıs 2026 A	10.750	0	$0
Leon Chen	·	06 Mayıs 2021 A	·	0	$0

SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış

ETF sahipliği 41 ETF'ler tarafından tutuluyor

20

Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.

Fon	Ağırlık	Birimler	Tarih itibarıyla	Kaynak
ARKG · ARK ETF Trust	2,51%	1.682.054 NS	31 Temmuz 2026	N-PORT
PTH · Invesco Exchange-Traded Fund Trust	1,24%	153.433 SH	02 Ekim 2026	Günlük
BBC · ETFis Series Trust I	0,92%	18.337 NS	31 Temmuz 2026	N-PORT
IWC · iShares Trust	0,59%	325.791 SH	11 Eylül 2026	Günlük
LABU · Direxion Shares ETF Trust	0,39%	83.566 NS	31 Temmuz 2026	N-PORT
FYC · First Trust Exchange-Traded AlphaDE…	0,38%	212.938 NS	31 Temmuz 2026	N-PORT
DWAS · Invesco Exchange-Traded Fund Trust …	0,36%	62.236 SH	02 Ekim 2026	Günlük
IBB · iShares Trust	0,19%	749.550 SH	11 Eylül 2026	Günlük
IBBQ · Invesco Exchange-Traded Fund Trust …	0,16%	7.333 SH	02 Ekim 2026	Günlük
IWO · iShares Trust	0,13%	693.157 SH	11 Eylül 2026	Günlük
FYX · First Trust Exchange-Traded AlphaDE…	0,12%	71.916 NS	31 Temmuz 2026	N-PORT
FFSM · FIDELITY COVINGTON TRUST	0,11%	71.221 NS	31 Temmuz 2026	N-PORT
PWS · Pacer Funds Trust	0,11%	1.142 NS	31 Temmuz 2026	N-PORT
VTWG · VANGUARD SCOTTSDALE FUNDS	0,11%	79.174 SH	19 Ağustos 2026	Günlük
PRFZ · Invesco Exchange-Traded Fund Trust	0,09%	103.798 SH	02 Ekim 2026	Günlük
IWM · iShares Trust	0,08%	2.461.076 SH	11 Eylül 2026	Günlük
FAD · First Trust Exchange-Traded AlphaDE…	0,08%	19.290 NS	31 Temmuz 2026	N-PORT
RSSL · Global X Funds	0,07%	45.904 NS	31 Temmuz 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,07%	551.605 SH	19 Ağustos 2026	Günlük
OMFS · Invesco Exchange-Traded Self-Indexe…	0,06%	6.461 SH	02 Ekim 2026	Günlük
DFAS · Dimensional ETF Trust	0,05%	313.021 NS	31 Temmuz 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,03%	1.114.166 SH	19 Ağustos 2026	Günlük
VTWV · VANGUARD SCOTTSDALE FUNDS	0,03%	19.327 SH	19 Ağustos 2026	Günlük
ISCG · iShares Trust	0,03%	9.673 SH	11 Eylül 2026	Günlük
FHLC · FIDELITY COVINGTON TRUST	0,02%	29.479 NS	31 Temmuz 2026	N-PORT
VHT · VANGUARD WORLD FUND	0,02%	186.845 SH	19 Ağustos 2026	Günlük
WSML · iShares Trust	0,02%	4.261 SH	11 Eylül 2026	Günlük
TILT · FlexShares Trust	0,01%	8.908 NS	31 Temmuz 2026	N-PORT
DFAC · Dimensional ETF Trust	0,01%	181.202 NS	31 Temmuz 2026	N-PORT
DCOR · Dimensional ETF Trust	0,01%	7.762 NS	31 Temmuz 2026	N-PORT
DFAU · Dimensional ETF Trust	0,00%	21.135 NS	31 Temmuz 2026	N-PORT
ITOT · iShares Trust	0,00%	136.268 SH	11 Eylül 2026	Günlük
IWV · iShares Trust	0,00%	27.695 SH	11 Eylül 2026	Günlük
DFSU · Dimensional ETF Trust	0,00%	3.425 NS	31 Temmuz 2026	N-PORT
DFUS · Dimensional ETF Trust	0,00%	16.122 NS	31 Temmuz 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0,00%	3.275.161 SH	19 Ağustos 2026	Günlük
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	7.909 SH	19 Ağustos 2026	Günlük
IWN · iShares Trust	·	210.645 SH	11 Eylül 2026	Günlük
ISCB · iShares Trust	·	3.438 SH	11 Eylül 2026	Günlük
ISCV · iShares Trust	·	10.240 SH	11 Eylül 2026	Günlük
SMLF · iShares Trust	·	88.041 SH	11 Eylül 2026	Günlük

NRIX Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

21

derecelendirme · 21 analist AL

Medyan hedef $34.00 +47,9%

7 33,3% Güçlü Al

12 57,1% Al

2 9,5% Tut

0 0,0% Sat

0 0,0% Güçlü Sat

12 Aylık Fiyat Hedefi

14 analist · 2026-09-29

Ortalama hedef $33.93 +47,6%

← Tüm hedeflerin altında Mevcut fiyat $22.99

Düşük$25.00 Ortalama$33.93 Yüksek$45.00

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

22

Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.

Hisse Sembolü	Piyasa Değeri	P/E	Gelir YoY	Net Kar Marjı	ROE	Brüt Kar Marjı
NRIX	$1.80B	-5.8	53.9%	-314.9%	-53.6%	·
PURR	$1.58B	2.5	·	3229.8%	24.8%	·
BEAM	$2.82B	-34.2	120.0%	-57.2%	-7.0%	·
IRON	$3.01B	-13.2	·	·	-31.3%	·
CLDX	$1.81B	-7.0	-78.0%	-16748.0%	-43.8%	·
IMNM	$2.43B	-8.8	-23.2%	-3060.0%	-47.0%	·
SLS	$577M	-15.1	·	·	-55.4%	·
VRDN	$3.17B	-7.7	23359.9%	-483.6%	-55.4%	·
RXRX	$2.16B	-2.8	26.9%	-863.4%	-62.9%	·

Son Haberler Bu şirketten bahseden son manşetler

23

Roche And Nurix Ink $2.3 Bln Collaboration To Co-Develop BTK Degrader Bexobrutideg Nasdaq · 3 ay, 3 hafta önce Nurix Therapeutics İlk Çeyrekte Daha Geniş Zarar Açıklandı Nasdaq · 5 ay, 3 hafta önce

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

26

Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

NRIX Nurix Therapeutics, Inc. - Common stock